AG00149V

13311-84-7 | Propanamide, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-

AG00149V

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	13311-84-7
Catalog Number	AG00149V(AGN-PC-0JEKVA)
Chemical Name	Propanamide, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-
EC Number	236-341-9
IUPAC Name	2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
InChI	InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)
InChI Key	MKXKFYHWDHIYRV-UHFFFAOYSA-N
MDL Number	MFCD00072009
Molecular Formula	C11H11F3N2O3
Molecular Weight	276.2118
SMILES	CC(C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F)C
UNII	76W6J0943E
Synonyms	Apimid, Apo Flutamide, Apo-Flutamide, ApoFlutamide, Chimax, Cytamid, Drogenil, Euflex, Eulexin, Eulexine, Fluken, Flulem, Flumid, Fluta 1A Pharma, Fluta cell, Fluta GRY, Fluta-cell, Fluta-GRY, Flutacell, FlutaGRY, Flutamide, Flutamin, Flutandrona, Flutaplex, Flutexin, Fugerel, Grisetin, Niftolid, Niftolide, Novo Flutamide, Novo-Flutamide, NovoFlutamide, Oncosal, PMS Flutamide, PMS-Flutamide, Prostacur, Prostica, Prostogenat, SCH 13521, SCH-13521, SCH13521, Testotard, flutamide, 13311-84-7, Niftolide, Eulexin, Niftholide, NFBA, niftolid, Flutamidum, Drogenil, Flutamida, 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide, Cebatrol, veterinary, Sch 13521, Flutamin, Sch-13521, 4'-Nitro-3'-trifluoromethylisobutyranilide, Ham's F-12 medium, Flutamidum [INN-Latin], Flutamida [INN-Spanish], Flutamide USP25, 2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide, Flutamide(Eulexin), NSC 215876, Flutamide (Eulexin), CCRIS 7246, Propanamide, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-, UNII-76W6J0943E, C11H11F3N2O3, EINECS 236-341-9, MFCD00072009, CHEMBL806, alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide, BRN 2157663, 4-Nitro-3-(trifluoromethyl)isobutyranilide, CHEBI:5132, N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)ISOBUTYRAMIDE, Propanamide, 2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, MKXKFYHWDHIYRV-UHFFFAOYSA-N, 76W6J0943E, NCGC00015452-09, CPD000058187, Eulexine, Chimax, 4'-Nitro-3'-trifluoromethylisobutyramilide, CAS-13311-84-7, DSSTox_CID_11121, DSSTox_RID_78899, DSSTox_GSID_32004, Prostandril, Cebatrol, Odyne, m-Propionotoluidide, 2-methyl-4'-nitro-alpha,alpha,alpha-triflouro-, SMR000058187, Eulexin (TN), Flutamide [USAN:BAN:INN], m-Propionotoluidide,.alpha.,.alpha.-trifluoro-, SR-01000075888, SCH13521, N1-[4-nitro-3-(trifluoromethyl)phenyl]-2-methylpropanamide, Flutamid, .alpha.,.alpha.-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide, m-Propionotoluidide,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-, 4'-Nitro-3'-(trifluoromethyl)isobutyranilide, Flutamide [USAN:USP:INN:BAN], Flutamide,(S), Prestwick_228, NK-601, ACMC-20hidt, PubChem13536, Spectrum_001210, 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide, AC1L1FUE, Prestwick0_000180, Prestwick1_000180, Prestwick2_000180, Prestwick3_000180, Spectrum2_001201, Spectrum3_001421, Spectrum4_000829, Spectrum5_001450, Lopac-F-9397, F0663, Flutamide (pubertal study), F 9397, SCHEMBL3934, Lopac0_000557, BSPBio_000079, BSPBio_003122, KBioGR_001377, KBioSS_001690, MLS000069634, MLS001065596, MLS002548892, DivK1c_000459, SPECTRUM1500995, SPBio_000982, SPBio_002000, Flutamide (JP17/USP/INN), BPBio1_000087, GTPL6943, DTXSID7032004, SCHEMBL12932289, CTK4B8363, HMS501G21, KBio1_000459, KBio2_001690, KBio2_004258, KBio2_006826, KBio3_002342, NINDS_000459, HMS1568D21, HMS1921O16, HMS2090I18, HMS2092O14, HMS2095D21, HMS2230P19, HMS3259I03, HMS3261P15, HMS3373C12, HMS3655G22, HMS3712D21, Pharmakon1600-01500995, BCP23006, HY-B0022, m-propionotoluidide,alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro, ZINC3812944, Tox21_110154, Tox21_202169, Tox21_300536, Tox21_500557, AN-025, BDBM50131270, CCG-39105, NSC147834, NSC215876, NSC757817, s1908, SBB006930, AKOS001025465, AKOS015994751, AKOS025243203, m-Propionotoluidide, .alpha.,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-, Tox21_110154_1, AB02835, CS-2359, DB00499, KS-5091, LP00557, LS-2105, MCULE-7498839065, NC00451, NSC-147834, NSC-215876, NSC-757817, IDI1_000459, KS-00000L22, NCGC00015452-01, NCGC00015452-02, NCGC00015452-03, NCGC00015452-04, NCGC00015452-05, NCGC00015452-06, NCGC00015452-07, NCGC00015452-08, NCGC00015452-10, NCGC00015452-11, NCGC00015452-12, NCGC00015452-13, NCGC00015452-14, NCGC00015452-15, NCGC00015452-16, NCGC00015452-19, NCGC00015452-20, NCGC00091460-01, NCGC00091460-02, NCGC00091460-03, NCGC00091460-04, NCGC00091460-05, NCGC00091460-06, NCGC00091460-07, NCGC00091460-08, NCGC00091460-09, NCGC00254495-01, NCGC00259718-01, NCGC00261242-01, AC-24192, AK499646, CJ-10770, SAM002264612, SC-12180, ST058409, SBI-0050540.P003, AB0005010, AB1010911, 3'-Trifluoromethyl-4'-Nitro-Isobutyranilide, AB00052188, EU-0100557, FT-0626493, SW196536-4, 4''-nitro-3''-trifluoromethylisobutyranilide, C07653, D00586, J10037, K-4175, AB00052188-09, AB00052188_10, AB00052188_11, 311F847, A806562, I01-2470, Q-201131, SR-01000075888-1, SR-01000075888-6, SR-01000075888-7, SR-01000075888-9, BRD-K28307902-001-05-0, Flutamide, certified reference material, TraceCERT(R), Z56755651, a,a,a-Trifluoro-2-methyl-4'-nitro- m-propionotoluidide, Flutamide, European Pharmacopoeia (EP) Reference Standard, 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide #, Flutamide, United States Pharmacopeia (USP) Reference Standard, Propanamide,2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-, alpha,alpha,alpha-trifluoro-2-methyl-4''-nitro-m-propionotoluidide, m-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-, Propanamide, 2-methyl-,N'-[4-nitro-3-(trifluoromethyl)phenyl]-, .alpha.,.alpha.,.alpha.-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide, m-Propionotoluidide, 2-methyl-4'-nitro-.alpha.,.alpha.,.alpha.-trifluoro-, m-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro- (8CI), Flutamide for system suitability, European Pharmacopoeia (EP) Reference Standard, 37209-54-4, PUBERTAL FLUTAMIDE STUDY (PUBERTAL STUDIES OF VINCLOZOLIN; METHOXYCHLOR; ETHINYL ESTRADIOL), Flutandrona, Prostogenat, Flutacell, Flutaplex, Flutexin, Prostacur, Prostica, Testotard, Cytamid, Fugerel, Oncosal, Apimid, ApoFlutamide, Fluken, Flulem, Flumid, NovoFlutamide, Novo Flutamide, Novo-Flutamide, Apo Flutamide, Apo-Flutamide, Fluta cell, Fluta-cell, flutopharm, methoxychlor, FlutaGRY, Grisetin, PMS Flutamide, PMS-Flutamide, Pamelor, Euflex, Fluta 1A Pharma, Fluta GRY, Fluta-GRY, Flutamide/Eulexin, Gry Brand of Flutamide, 1A Brand of Flutamide, Juta Brand of Flutamide, TAD Brand of Flutamide, InibsaBrand of Flutamide, Essex Brand of Flutamide, Hexal Brand of Flutamide, Ipsen Brand of Flutamide, Flutamide(pubertal study), ETHINYL ESTRADIOL), Apotex Brand of Flutamide, Chiron Brand of Flutamide, Ciclum Brand of Flutamide, Flutamide (AR inhibitor), Lemery Brand of Flutamide, esparma Brand of Flutamide, D0Y0SW, Apogepha Brand of Flutamide, Kendrick Brand of Flutamide, Q Pharm Brand of Flutamide, Q-Pharm Brand of Flutamide, Schering Brand of Flutamide, Azupharma Brand of Flutamide, Flutamide (JAN/USP/INN), Novopharm Brand of Flutamide, Prasfarma Brand of Flutamide, Alphapharm Brand of Flutamide, Chephasaar Brand of Flutamide, Flutamide [USAN:INN:BAN], cell pharm Brand of Flutamide, Tedec Meiji Brand of Flutamide, Pharmascience Brand of Flutamide, CID3397, Schering Plough Brand of Flutamide, Schering-Plough Brand of Flutamide, Eulexin, Flutamin, Drogenil,Flutamide, C11-H11-F3-N2-O3, CS-O-11652, B1376, A10402, D005485, FTA, Propanamida, 2-metil-N-[4-nitro-3-(trifluorometil)fenil]-, Flutamide, 98%, an androgen receptor antagonist - 25G 25g, PUBERTAL FLUTAMIDE STUDY (PUBERTAL STUDIES OF VINCLOZOLIN, M-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-(8CI),

Complexity	352
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	276.072g/mol
Formal Charge	0
Heavy Atom Count	19
Hydrogen Bond Acceptor Count	6
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	276.215g/mol
Monoisotopic Mass	276.072g/mol
Rotatable Bond Count	2
Topological Polar Surface Area	74.9A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	3.3

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335-H350-H360
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number